Case Studies

The plasma lipidome in anorexia patients before and after refeeding therapy exhibits dysregulated lipid metabolism.

The plasma lipid profile depends on meal timing and composition and is associated with insulin sensitivity.

The enzyme PTPMT1, which synthesizes the mitochondrial lipid cardiolipin, helps cancer cells adapt to hypoxia.

Multiomics analyses with lipidomics reveal molecular pathways in Alzheimer’s disease to improve predictive power.

Metabolic indicators in the plasma lipidome can classify obesity status more accurately than standard metrics.

Skin lipid composition impacts skin health and can be studied via lipidomics but sex, age and, sample depth affect the data.

Heart failure changes lipid metabolism in cardiac tissue of mice. The altered lipid profile can be confirmed in human plasma.

Combined transcriptomic, proteomic, lipidomic, & metabolomic analyses can characterize the molecular basis of diabetes.

Exosomes may be useful for targeted drug delivery. Proteomic & lipidomic characterization are required for this goal.

Breast cancer phospholipid metabolism is a powerful target for new therapies, especially against triple-negative breast cancer.

The brain of mammals is the second-most lipid-rich organ. Lipid analysis of neural cells helps understand its complex structure.

Diagnosing multiple sclerosis is difficult. Lipid markers can support diagnosis and treatment of the neuroinflammatory disease.

A population health study examined the relationships between genotypes, the plasma lipidome, and cardiovascular diseases.

Skin biology is central to develop reliable moisturizers, but molecular analysis of the skin has been lacking.

The development of new antibiotics alone is not believed to stop multi resistant bacteria. A new strategy is emerging.